Lipocine Inc. 8-K

What Happened
Lipocine Inc. (LPCN) announced in an 8-K filed June 4, 2026 that it will host a virtual Key Opinion Leader (KOL) event on Friday, June 12, 2026 at 11:00 AM Eastern Time. The event will highlight unmet needs in postpartum depression and review the clinical profile of the company’s development candidate LPCN 1154. The announcement was made via a press release furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: June 4, 2026 (Form 8-K, Item 8.01 - Other Events).
• Event date/time: June 12, 2026 at 11:00 AM Eastern Time.
• Topic: Unmet needs in postpartum depression and clinical profile of LPCN 1154.
• Press release: Furnished as Exhibit 99.1 to the 8-K.

Why It Matters
This event provides investors and analysts an opportunity to hear expert perspectives on postpartum depression and details about LPCN 1154, which is part of Lipocine’s clinical pipeline. While the 8-K does not disclose new clinical data or timelines, the KOL discussion could offer insights into the market need, potential clinical positioning, and next steps for LPCN 1154 that may be relevant for evaluating the company’s development progress.